Recursion Pharmaceuticals (RXRX) EPS (2020 - 2026)
Recursion Pharmaceuticals (RXRX) EPS from Mar 31, 2020 to Mar 31, 2026. The TTM Recursion Pharmaceuticals (RXRX) EPS is -$1.15. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Recursion Pharmaceuticals (RXRX) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -17.86% |
| 3 Years TTM | +8.15% |
| 5 Years TTM | -10.03% |
| All Time TTM | -10.03% |
Annual EPS change of Recursion Pharmaceuticals (RXRX)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.22 | -81.86% |
| 2025 | -$1.22 | +56.70% |
| 2024 | -$0.78 | -16.56% |
| 2023 | -$0.93 | +11.70% |
| 2022 | -$0.84 | +14.47% |
| 2021 | -$0.73 | -58.67% |
| 2020 | -$1.77 | N/A |
Comparison Recursion Pharmaceuticals (RXRX) five years EPS CAGR with competitors
Recursion Pharmaceuticals (RXRX) five years EPS CAGR is -10.03%.